Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Scientists say that adding a daily dose of spermidine can boost immune function in older adults. The team of immunologists and gerontologists reported that, in a placebo-controlled randomized trial, seniors who sipped a spermidine supplement kicked their adaptive immune system back into gear. In this phase 1 pilot study, pensioners who took 6 mg of spermidine after […]

The post Senior Citizens Can Kickstart Vaccine Response With Simple Supplement appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Does getting healthcare sound simple? You only really feel it when you try doing it yourself. The real struggle for people in low income or underserved communities starts long before they see a doctor. It starts with a phone call that no one picks up or a clinic line, which makes you wait for 20 […]

The post Can AI Improve Healthcare Access for Underserved Communities? appeared first on Medical News Bulletin.

The Supreme Court struck down President Donald J. Trump’s executive order to end universal birthright citizenship in the United States, protecting health care access to all babies born in the country.
Trump signed an executive order in January of 2025 declaring that babies born to parents who were in the country unlawfully or temporarily should not automatically be granted citizenship.
The Supreme Court ruled 6-3 against the order, with Justices Samuel Alito, Neil Gorsuch and Clarence Thomas dissenting. In the majority opinion, Chief Justice John Roberts wrote that the executive order violated

The latest rewrite of the charter for the CDC’s influential vaccine advisory committee could fundamentally alter the panel’s responsibilities and negatively impact access to vaccines, experts warned.
The rewritten charter, which was posted on the CDC’s website last week, says the Advisory Committee on Immunization Practices “may consider the availability and effectiveness of other preventive measures, including nonvaccine interventions, where relevant to assessing the appropriate use of vaccines.”
It also loosens previous requirements that mandated members hold

DENVER — In a phase 1b trial, subretinal delivery of a human stem cell-derived retinal pigment epithelium yielded visual improvements in patients with advanced geographic atrophy, according to a speaker.
“This study looked at subretinal stem cell implants through a pars plana vitrectomy surgery, where we created a bleb directly over the site of geographic atrophy,” Vivienne S. Hau, MD, PhD, told Healio at the Association for Research in Vision and Ophthalmology meeting. “Through that, it was hoped that the human embryonic stem cells would integrate and form [retinal pigment epithelium] cells,

The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.
According to an FDA press release, marketing of these products can now include the modified risk claim that “using Zyn instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.”
The Zyn products included in this announcement are Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint and Wintergreen. Each flavor has a 3 mg and 6 mg nicotine

HHS Secretary Robert F. Kennedy Jr. is moving to terminate COVID-19 emergency use authorization declarations for drugs, biologics and medical devices, the agency announced.
“Americans deserve a regulatory system that is transparent, accountable and rooted in the rule of law,” Kennedy Jr. said in a press release. “By ending these COVID-19 emergency use authorization declarations, we’re reinforcing public confidence that emergency authorities are temporary and targeted.”
According to HHS, these terminations will take place over advanced notice periods “to ensure an orderly transition.”

CHICAGO — Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized phase 3 trial.
The benefit appeared particularly strong among women, data presented at ASCO Annual Meeting showed.
The findings support consideration of bupropion as a potential treatment for cancer-related fatigue provided patients are appropriately screened to avoid established contraindications, Luke J. Peppone, PhD, MPH, associate professor in the division of supportive care in cancer at University of Rochester Medical Center, and colleagues concluded.

The FDA granted priority review to a supplemental biologics license application for Enspryng for thyroid eye disease, according to a press release from Genentech.
Enspryng (satralizumab) is currently approved for the treatment of neuromyelitis optica spectrum disorder in patients who are aquaporin-4 antibody positive. If approved, it would become the first at-home subcutaneous treatment option for thyroid eye disease (TED).
The FDA ruling was supported by data from the phase 3 randomized, placebo-controlled global SatraGO program, which investigated Enspryng’s safety and efficacy in moderate to

PARK CITY, Utah — A five-grade imaging classification system and diagnostic therapeutic algorithm may reduce the risk for primary periphyseal stress injuries among young rock climbers, according to a presenter here.
“[Primary periphyseal stress injury (PPSI)] is the most common injury among youth climbers. Lower grade lead climbers who are younger than age 16 have become this new vulnerable group for PPSIs,” Rachel Meyers, PT, DPT, at Children’s Hospital Colorado, said in her presentation at the International Extreme Sports Medicine Congress. “There are a lot of